Sign in
Back
Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio
Journal article   Open access  Peer reviewed

Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio

Aboubakr Elnashar, Hany Fouad, Magy Eldosoky, Naser Saeid and hassan Fouad elsayed
Fertility and sterility, Vol.85(2), pp.511-513
01/02/2006
DOI: https://doi.org/10.1016/j.fertnstert.2005.08.016
PMID: 16595244

Abstract

Adult Aromatase Inhibitors - therapeutic use Body Mass Index Clomiphene - therapeutic use Drug Resistance Female Fertility Agents, Female - therapeutic use Follicle Stimulating Hormone - blood Humans Infertility, Female - drug therapy Infertility, Female - etiology Infertility, Female - physiopathology Luteinizing Hormone - blood Nitriles - therapeutic use Ovulation - drug effects Ovulation Induction - methods Polycystic Ovary Syndrome - complications Pregnancy Pregnancy Rate Retreatment Triazoles - therapeutic use
Letrozole induction of ovulation in clomiphene citrate-resistant women with polycystic ovary syndrome is associated with an ovulation rate of 54.6% and pregnancy rate of 25%. There was no significant difference between letrozole responders and nonresponders in age, period of infertility, body mass index, waist circumference, LH, FSH, or LH/FSH ratio.
url
https://doi.org/10.1016/j.fertnstert.2005.08.016View
Published (Version of record) Open

Metrics

1 Record Views

Details